Skip to main content
Log in

The neuroendocrine tumors of the ileum

  • Review Article
  • Published:
Central European Journal of Medicine

Abstract

Neuroendocrine tumors arise from the diffuse neuroendocrine system and secrete several peptides and bioactive amines (serotonin, histamine, dopamine, norepinephrine, corticotropin, calcitonin, bradykinin, kalikrein, gastrin, cholecystokinin, prostaglandins). The most common occurrence site of neuroendocrine tumors is the ileum. The symptoms of small bowel carcinoids are represented by intermittent intestinal obstruction and carcinoid syndrome. Presence of the carcinoid syndrome usually indicates hepatic or retroperitoneal metastases. The typical carcinoid syndrome is characterized by flushing, diarrhea, nonspecific abdominal pain and bronchospasm. The diagnosis of small bowel tumors is often difficult due to their rarity and the nonspecific and variable nature of the presenting signs and symptoms. The most useful initial diagnostic test for the carcinoid syndrome is to measure 24-hour urinary excretion of 5-hydroxyindolacetic acid (5 HIAA), which is the end product of serotonin metabolism. Capsule endoscopy is a more recent diagnostic tool. Surgery is the radical form of curative therapy for carcinoid tumors. Numerous therapies are available for palliation including surgery, pharmacologic therapy, interventional radiologic therapy, embolization and chemoembolization of hepatic metastases, immunotherapy (Interferon alfa) and chemotherapy. We carefully reviewed the available literature on this topic before beginning our study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Feldman M., Friedman L.S., Brandt L.J., Gastrointestinal carcinoid tumors and the carcinoid syndrome, Sleisenger & Fordtran’s Gastrointestinal and Liver Disease, 8th ed., 2006

  2. Janmohamed S., Bloom S.R., Carcinoid tumours, Postgrad Med J., 1997, 73, 207–214

    Article  PubMed  CAS  Google Scholar 

  3. Caplin M.E., Buscombe J.R., Hilson A.J., Jones A.L., Watkinson A.F., Burroughs A.K., Carcinoid tumour, Lancet 1998, 352, 799–805

    Article  PubMed  CAS  Google Scholar 

  4. Modlin I.M., Sandor A., An analysis of 8305 cases of carcinoid tumors, Cancer, 1997, 79, 813–829

    Article  PubMed  CAS  Google Scholar 

  5. Timmins P.F., Kuo D.Y., Anderson P.S., Fields A.L., Whitney K.D., Goldberg G.L., Ovarian carcinoid: Management of primary and recurrent tumors, Gynecol Oncol., 2000, 76,112–114

    Article  PubMed  CAS  Google Scholar 

  6. Yokoyama Y., Fujioka S., Kato K., Tomono H., Yoshida K., Nimura Y., Primary carcinoid tumor of the gallbladder: Resection of a case metastasizing to the liver and analysis of outcomes, Hepatogastroenterology, 2000, 47, 135–139

    PubMed  CAS  Google Scholar 

  7. Chamberlain R.S., Blumgart L.H., Carcinoid tumors of the extrahepatic bile duct: A rare cause of malignant biliary obstruction, Cancer, 1999, 86, 1959–1965

    Article  PubMed  CAS  Google Scholar 

  8. Fukai I., Masaoka A., Fujii Y., Thymic neuroendocrine tumor (thymic carcinoid): A clinicopathologic study in 15 patients, Ann. Thorac. Surg., 1999, 67, 208–211

    Article  PubMed  CAS  Google Scholar 

  9. Glazier D.B., Murphy D.P., Barnard N., Cummings K.B., Weiss R.E., Primary carcinoid tumour of the testis, British Journal of Urology Int., 1999, 83, 153–154

    CAS  Google Scholar 

  10. Kehagias D., Moulopoulos L., Smirniotis V., Pafiti A., Ispanopoulos S., Vlahos L., Imaging findings in primary carcinoid tumour of the liver with gastrin production, Br. J. Radiol., 1999, 72, 207–209

    PubMed  CAS  Google Scholar 

  11. Burke A.P., Thomas R.M., Elsayed A.M., Sobin L.H., Carcinoids of the jejunum and ileum: An immunohistochemical and clinicopathologic study of 167 cases, Cancer, 1997, 79, 1086–1090

    Article  PubMed  CAS  Google Scholar 

  12. Yang K., Ulich T., Cheng L., Lewin K.J., The neuroendocrine products of intestinal carcinoids: An immunoperoxidase study of 35 carcinoid tumors stained for serotonin and eight polypeptide hormones, Cancer, 1997, 51, 1918–1926

    Article  Google Scholar 

  13. Modlin I.M., Kidd M., Latich I., Zikusoka M.N., Shapiro MD., Current status of gastrointestinal carcinoids, Gastroenterology, 2005, 128, 1717–1751

    Article  PubMed  Google Scholar 

  14. Marshall J.B., Bornarchuk G., Carcinoid tumors of the gut, J. Clin. Gastroenterol., 1993, 16, 123–140

    Article  PubMed  CAS  Google Scholar 

  15. Feldman J.M., Carcinoid tumor and syndrome, Semin Oncol., 1987, 15, 237–246

    Google Scholar 

  16. Ahlman H., Dahlstrom A., Gronstad K., The pentagastrin test in the diagnosis of the carcinoid syndrome: Blockade of gastrointestinal symptoms by ketanserin, Ann. Surg., 1985, 201, 81–86

    Article  PubMed  CAS  Google Scholar 

  17. Cwikła J.B., Buscombe J.R., Caplin M.E., Watkinson A.F., Walecki J., Gorczyca-Wiśniewska E., et al., Diagnostic imaging of carcinoid metastases to the abdomen and pelvis, Med. Sci. Monit., 2004, 10 Suppl., 3, 9–16

    Google Scholar 

  18. Grahame-Smith D.G., The carcinoid syndrome, William Heineman Medical Books, London, 1972

    Google Scholar 

  19. Vaughan D.J., Brunner M.D., Anesthesia for patients with carcinoid syndrome, Int Anesthesiol Clin., 1997, 35, 129–142

    Article  PubMed  CAS  Google Scholar 

  20. Onaitis M.W., Kirshbom P.M., Hayward T.Z., Gastrointestinal carcinoids: characterization by site of origin and hormone production, Ann Surg., 2000, 232, 549–561

    Article  PubMed  CAS  Google Scholar 

  21. Nehar D., Lombard-Bohas C., Olivieri S., Claustrat B., Chayvialle J.A., Penes M.C., Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours, Clinical Endocrinology,2004, 60, 644–652

    Article  PubMed  CAS  Google Scholar 

  22. D’Halluin P.N., Delvaux M., Lapalus M.G., Sacher-Huvelin S., Ben Soussan E., Heyries L., et al., Does the “Suspected Blood Indicator” improve the detection of bleeding lesions by capsule endoscopy? 2005, 61, 243–249

    Google Scholar 

  23. Schmidt S., Felley C., Meuwly J.Y., Schnyder P., Denys A., CT enteroclysis: technique and clinical applications, Eur. Radiol., 2006, 16, 648–660

    Article  PubMed  Google Scholar 

  24. Soga J., Early-stage carcinoids of the gastrointestinal tract, Cancer, 2005, 103, 1587–1595

    Article  PubMed  Google Scholar 

  25. Arnold R., Medical treatment of metastasizing carcinoid tumors, World J. Surgery, 1996, 20, 203–207

    Article  CAS  Google Scholar 

  26. Creutzfeldt W., Carcinoid tumors: Development of our knowledge, World J. Surgery, 1996, 20, 126–131

    Article  CAS  Google Scholar 

  27. Sokmensuer C., Gedikoglu G., Uzunalimoglu B., Importance of proliferation markers in gastrointestinal carcinoid tumors: a clinicopathologic study, Hepatogastroenterology, 2001, 48, 720–723

    PubMed  CAS  Google Scholar 

  28. Loftus J.P., Van Heerden J.A., Surgical management of gastrointestinal carcinoid tumors, Adv. Surgery, 1995, 28, 317–321

    CAS  Google Scholar 

  29. Rorstad O., Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract, J. Surg. Oncol., 2005, 89, 151–160

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dan L. Dumitrascu.

About this article

Cite this article

Costin, S., Dumitrascu, D.L. The neuroendocrine tumors of the ileum. cent.eur.j.med 3, 135–140 (2008). https://doi.org/10.2478/s11536-008-0010-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2478/s11536-008-0010-5

Keywords

Navigation